Publication:
The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.

Simple item page
dc.contributor.authorUSTAALIOĞLU, BB
dc.contributor.authorBILICI, A
dc.contributor.authorERCAN, S
dc.contributor.authorSeker, MESUT
dc.contributor.authorORCUN, A
dc.contributor.authorGUMUS, M
dc.contributor.institutionauthorŞEKER, MESUT
dc.date.accessioned2020-10-29T22:17:31Z
dc.date.available2020-10-29T22:17:31Z
dc.date.issued2013-06-01T00:00:00Z
dc.identifier.citationUSTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M., -The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.-, Medical oncology (Northwood, London, England), cilt.30, ss.551, 2013
dc.identifier.doi10.1007/s12032-013-0551-6
dc.identifier.scopus84875343575
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26521
dc.identifier.wosWOS:000319450400059
dc.titleThe prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.
dc.typeArticle
dspace.entity.typePublication
local.avesis.idab112cab-8f29-4c7c-af56-f45c4d5949dc
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication8a03684e-e421-4a9f-9069-168fc121a5d4
relation.isAuthorOfPublication.latestForDiscovery8a03684e-e421-4a9f-9069-168fc121a5d4
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Silinecekler